Jan J. Heimans

5.3k total citations
63 papers, 3.9k citations indexed

About

Jan J. Heimans is a scholar working on Cognitive Neuroscience, Genetics and Oncology. According to data from OpenAlex, Jan J. Heimans has authored 63 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cognitive Neuroscience, 19 papers in Genetics and 15 papers in Oncology. Recurrent topics in Jan J. Heimans's work include Glioma Diagnosis and Treatment (19 papers), Functional Brain Connectivity Studies (18 papers) and Neural dynamics and brain function (16 papers). Jan J. Heimans is often cited by papers focused on Glioma Diagnosis and Treatment (19 papers), Functional Brain Connectivity Studies (18 papers) and Neural dynamics and brain function (16 papers). Jan J. Heimans collaborates with scholars based in Netherlands, United States and Belgium. Jan J. Heimans's co-authors include Jaap C. Reijneveld, Martin Klein, Tjeerd J. Postma, Cornelis J. Stam, Linda Douw, Neil K. Aaronson, Martin Klein, Edwin van Dellen, Eleonora Aronica and Ingeborg Bosma and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and NeuroImage.

In The Last Decade

Jan J. Heimans

63 papers receiving 3.8k citations

Peers

Jan J. Heimans
Andrei I. Holodny United States
Thomas Czech Austria
J.J. Heimans Netherlands
Linda Douw Netherlands
Irina Mader Germany
Andrei I. Holodny United States
Jan J. Heimans
Citations per year, relative to Jan J. Heimans Jan J. Heimans (= 1×) peers Andrei I. Holodny

Countries citing papers authored by Jan J. Heimans

Since Specialization
Citations

This map shows the geographic impact of Jan J. Heimans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan J. Heimans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan J. Heimans more than expected).

Fields of papers citing papers by Jan J. Heimans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan J. Heimans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan J. Heimans. The network helps show where Jan J. Heimans may publish in the future.

Co-authorship network of co-authors of Jan J. Heimans

This figure shows the co-authorship network connecting the top 25 collaborators of Jan J. Heimans. A scholar is included among the top collaborators of Jan J. Heimans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan J. Heimans. Jan J. Heimans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Postma, Tjeerd J., Marinus A. Blankenstein, Maaike J. Vos, et al.. (2016). Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis. Journal of Neuro-Oncology. 129(3). 525–532. 19 indexed citations
2.
Ediebah, Divine, Jaap C. Reijneveld, Martin Klein, et al.. (2016). Impact of neurocognitive deficits on patient–proxy agreement regarding health-related quality of life in low-grade glioma patients. Quality of Life Research. 26(4). 869–880. 30 indexed citations
3.
Sizoo, Eefje M., Martin Klein, Bernard M.J. Uitdehaag, et al.. (2013). The End-of-Life Phase of High-Grade Glioma Patients: Dying With Dignity?. The Oncologist. 18(2). 198–203. 58 indexed citations
4.
Dellen, Edwin van, Arjan Hillebrand, Linda Douw, et al.. (2013). Local polymorphic delta activity in cortical lesions causes global decreases in functional connectivity. NeuroImage. 83. 524–532. 60 indexed citations
5.
Boele, Florien, Jan J. Heimans, Neil K. Aaronson, et al.. (2013). Health-related quality of life of significant others of patients with malignant CNS versus non-CNS tumors: a comparative study. Journal of Neuro-Oncology. 115(1). 87–94. 40 indexed citations
6.
Sizoo, Eefje M., Johan A F Koekkoek, Tjeerd J. Postma, et al.. (2013). Seizures in patients with high-grade glioma: a serious challenge in the end-of-life phase. BMJ Supportive & Palliative Care. 4(1). 77–80. 19 indexed citations
7.
Zurolo, Emanuele, Marjolein de Groot, Anand M. Iyer, et al.. (2012). Regulation of Kir4.1 expression in astrocytes and astrocytic tumors: a role for interleukin-1 β. Journal of Neuroinflammation. 9(1). 280–280. 54 indexed citations
8.
Boele, Florien, Eefje M. Sizoo, Emma H. Collette, et al.. (2012). Enhancing quality of life and mastery of informal caregivers of high-grade glioma patients: a randomized controlled trial. Journal of Neuro-Oncology. 111(3). 303–311. 85 indexed citations
9.
Postma, T.J. & Jan J. Heimans. (2012). Neurological complications of chemotherapy to the peripheral nervous system. Handbook of clinical neurology. 105. 917–936. 3 indexed citations
10.
Sizoo, Eefje M., H. Roeline W. Pasman, Jan J. Heimans, et al.. (2011). Decision-making in the end-of-life phase of high-grade glioma patients. European Journal of Cancer. 48(2). 226–232. 82 indexed citations
11.
Groot, Marjolein de, Anand M. Iyer, Emanuele Zurolo, et al.. (2011). Overexpression of ADK in human astrocytic tumors and peritumoral tissue is related to tumor‐associated epilepsy. Epilepsia. 53(1). 58–66. 64 indexed citations
12.
Douw, Linda, Edwin van Dellen, Marjolein de Groot, et al.. (2010). Epilepsy is related to theta band brain connectivity and network topology in brain tumor patients. BMC Neuroscience. 11(1). 103–103. 136 indexed citations
13.
Groot, M. de, Karin Boer, Wim G.M. Spliet, et al.. (2010). Expression of synaptic vesicle protein 2A in epilepsy-associated brain tumors and in the peritumoral cortex. Neuro-Oncology. 12(3). 265–273. 33 indexed citations
14.
Bosma, Ingeborg, Jaap C. Reijneveld, Martin Klein, et al.. (2009). Disturbed functional brain networks and neurocognitive function in low-grade glioma patients: a graph theoretical analysis of resting-state MEG. PubMed. 3(1). 9–9. 108 indexed citations
15.
Bartoloméi, Fabrice, Ingeborg Bosma, Martin Klein, et al.. (2006). Disturbed functional connectivity in brain tumour patients: Evaluation by graph analysis of synchronization matrices. Clinical Neurophysiology. 117(9). 2039–2049. 219 indexed citations
16.
Buis, Dennis R., et al.. (2006). Acquired encephaloceles and epilepsy in osteopetrosis. Acta Neurochirurgica. 149(1). 79–81. 13 indexed citations
17.
Baayen, Johannes C., Arent de Jongh, Cornelis J. Stam, et al.. (2003). Localization of Slow Wave Activity in Patients with Tumor-Associated Epilepsy. Brain Topography. 16(2). 85–93. 46 indexed citations
18.
Rijn, J. van, Jan J. Heimans, Jaap van den Berg, Paul van der Valk, & Ben J. Slotman. (2000). Survival of human glioma cells treated with various combination of temozolomide and X-rays. International Journal of Radiation Oncology*Biology*Physics. 47(3). 779–784. 115 indexed citations
19.
Jonkhoff, Andries R., Peter C. Huijgens, W. O. Schreuder, G. J. J. Teule, & Jan J. Heimans. (1993). Hypophyseal Non-Hodgkin's Lymphoma presenting with clinical panhypopituitarism successfully treated with chemotherapy. Journal of Neuro-Oncology. 17(2). 155–158. 27 indexed citations
20.
Langeveld, Cornelis H., et al.. (1992). Implication of glucocorticoid receptors in the stimulation of human glioma cell proliferation by dexamethasone. Journal of Neuroscience Research. 31(3). 524–531. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026